A Phase III, Randomized Clinical Trial to Study the Safety and Efficacy of MK-906 (Finasteride) and Tamsulosin Administered Either Alone or Concomitantly in Patients With Benign Prostatic Hyperplasia (BPH).

Trial Profile

A Phase III, Randomized Clinical Trial to Study the Safety and Efficacy of MK-906 (Finasteride) and Tamsulosin Administered Either Alone or Concomitantly in Patients With Benign Prostatic Hyperplasia (BPH).

Discontinued
Phase of Trial: Phase III

Latest Information Update: 24 Jun 2017

At a glance

  • Drugs Finasteride (Primary) ; Tamsulosin
  • Indications Benign prostatic hyperplasia
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 02 Dec 2015 Primary endpoint related to adverse events were added, trial focus changed, as reported by ClinicalTrials.gov.
    • 26 Nov 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 04 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top